These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28052036)

  • 1. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
    Zeng H; Ortiz A; Shen PF; Cheng CJ; Lee YC; Yu G; Lin SC; Creighton CJ; Yu-Lee LY; Lin SH
    Oncotarget; 2017 Feb; 8(6):10145-10160. PubMed ID: 28052036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
    Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
    Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
    Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
    J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.
    Hong W
    Sci Signal; 2013 Sep; 6(291):pe27. PubMed ID: 24003252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
    Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiomotin promotes breast cancer cell proliferation and invasion.
    Lv M; Lv M; Chen L; Qin T; Zhang X; Liu P; Yang J
    Oncol Rep; 2015 Apr; 33(4):1938-46. PubMed ID: 25647626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling.
    Wang H; Lu B; Castillo J; Zhang Y; Yang Z; McAllister G; Lindeman A; Reece-Hoyes J; Tallarico J; Russ C; Hoffman G; Xu W; Schirle M; Cong F
    J Biol Chem; 2016 Jul; 291(29):15256-66. PubMed ID: 27231341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced expression of AMOT reverses adriamycin resistance in breast cancer cells.
    Zhang H; Wang Y; Gao Y; Du M; Pan E; Sun M; Zhang X
    Cell Biol Int; 2024 Sep; 48(9):1301-1312. PubMed ID: 39021301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiomotins link F-actin architecture to Hippo pathway signaling.
    Mana-Capelli S; Paramasivam M; Dutta S; McCollum D
    Mol Biol Cell; 2014 May; 25(10):1676-85. PubMed ID: 24648494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiomotin Family Members: Oncogenes or Tumor Suppressors?
    Lv M; Shen Y; Yang J; Li S; Wang B; Chen Z; Li P; Liu P; Yang J
    Int J Biol Sci; 2017; 13(6):772-781. PubMed ID: 28656002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.
    Moleirinho S; Hoxha S; Mandati V; Curtale G; Troutman S; Ehmer U; Kissil JL
    Elife; 2017 May; 6():. PubMed ID: 28464980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.
    Chan SW; Lim CJ; Guo F; Tan I; Leung T; Hong W
    J Biol Chem; 2013 Dec; 288(52):37296-307. PubMed ID: 24225952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.
    Kim M; Kim M; Park SJ; Lee C; Lim DS
    EMBO Rep; 2016 Jan; 17(1):64-78. PubMed ID: 26598551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiomotin family proteins in the Hippo signaling pathway.
    Wang Y; Yu FX
    Bioessays; 2024 Aug; 46(8):e2400076. PubMed ID: 38760875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
    Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
    Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.